[1]张庆芝, 杨雅程, 赵天翊, 雷家骕.科学家参与、知识转移与基于科学的企业持续创新[J].科学学研究, 2019, 37(11):2082-2091
[2] 胥和平, 雷家骕.前瞻布局基于科学的产业创新 培育先发优势的引领性发展[N]. 科技日报, 2021-04-09(008).
[3] 中华人民共和国中央人民政府.中华人民共和国国民经济和社会发展第十四个五年规划和 2035 年远景目标纲要[EB/OL]. 2021-03-13[2021-11-26]. http://www.gov.cn/xinwen/2021-03/13/content_5592681.htm.
[4] 雷家骕.粤港澳大湾区应着重发展基于科学的产业[N]. 科技日报, 2018-10-19(007).
[5]王茜.帮助企业跨越“死亡之谷”——英国政府的“有所为”与“有所不为[J].全球科技经济瞭望, 2015, 30(08):22-26
[6] 董文玲.科技型中小企业如何跨越“死亡谷”——基于政府作用分析[J].现代经济信息, 2017(01):80.
[7]周程, 张杰军.跨越创新过程中的“死亡之谷”——科技成果产业化问题刍议[J].科学学与科学技术管理, 2010, 31(03):50-55
[8]田华, 田中.美国国防高级研究计划局如何跨越“死亡之谷[J].科学学研究, 2012, 30(11):1627-1633
[9]周程.死亡之谷”何以能被跨越?——汉字激光照排系统的产业化进程研究[J].自然辩证法通讯, 2010, 32(02):30-42
[10] 秦洁, 张恒超.科技型中小企业应如何跨越“死亡之谷”[J].中国高校科技, 2015(10):90-93.
[11] 智瑞芝.区域创新视角下的日本大学衍生企业研究[D].华东师范大学, 2007.
[12]李新宁.战略性新兴产业技术创新治理:“死亡之谷”的视角[J].西安财经学院学报, 2019, 32(06):58-65
[13] 方放, 王道平, 张志东.跨越低碳技术“死亡之谷”公共部门与私有部门投资者协同创新研究——基于信息不对称视角[J].中国软科学, 2016(01):138-145.
[14] 李晓华, 柯罗马.跨越死亡之谷:以大学风险投资激活科技成果转化系统为例[J].清华管理评论, 2021(09):51-59.
[15] Lin William Cong, Charles M.C.Lee, 屈源育, 沈涛.“死亡之谷”和“退出陷阱”羁绊中国创业企业——中国初创企业的融资现状与困境[J].清华管理评论, 2019(09):34-40.
[16] 王雪青, 邴兴国, 李艳学.天使投资在政府对科技型中小企业科技投入中的应用研究[J].东南大学学报(哲学社会科学版), 2008(05):19-23+126.
[17] 杨倬妮, 苏竣.天使投资让科技型中小企业走出死亡之谷[J].中国高校科技与产业化, 2006(04):46-48.
[18] 沈梓鑫, 贾根良.美国在颠覆式创新中如何跨越“死亡之谷”?[J].财经问题研究, 2018(05):90-98.
[19]Almeida P, Hohberger J, Parada P.Individual scientific collaborations and firm-level innovation[J].Industrial and corporate Change, 2011, 20(6):1571-1599
[20] Baba, Y., Shichijo, N., & Sedita, S. R. (2009). How do collaborations with universities affect firms’ innovative performance? The role of “Pasteur scientists” in the advanced materials field. Research Policy, 38(5), 756-764.
[21] Wright M.Academic entrepreneurship in Europe[M]. Edward Elgar Publishing, 2007-04-25.
[22]Rasmussen E, Wright M.How can universities facilitate academic spin-offs? An entrepreneurial competency perspective[J].The Journal of Technology Transfer, 2015, 40(5):782-799
[23]Huyghe A, Knockaert M, Wright M, et al.Technology transfer offices as boundary spanners in the pre-spin-off process: The case of a hybrid model[J].Small Business Economics, 2014, 43(2):289-307
[24]Ramaciotti L, Rizzo U.The determinants of academic spin‐off creation by Italian universities[J].R& D Management, 2015, 45(5):501-514
[25]Chen M H, Chang Y C, Hung S C.Social capital and creativity in R&D project teams[J].R& d Management, 2008, 38(1):21-34
[26]Bruno Armano, Simone Domenico Scagnelli.Academic entrepreneurs’ role in science-based companies[J].European Journal of Innovation Management, 2012, 15(2):192-211
[27]Shu C, Wang Q, Gao S, et al.Firm patenting,innovations,and government institutional support as a double‐edged sword[J].Journal of Product Innovation Management, 2015, 32(2):290-305
[28]Branstetter L G, Sakakibara M.When do research consortia work well and why? Evidence from Japanese panel data[J].American Economic Review, 2002, 92(1):143-159
[29]Jong S.How organizational structures in science shape spin-off firms: the biochemistry departments of Berkeley,Stanford,and UCSF and the birth of the biotech industry[J].Industrial and Corporate Change, 2006, 15(2):251-283
[30]S.Suresh KumarComponents of Science-Based Innovation Measurements and Their Links to Public Policies[J].Technological Forecasting & Social Change, 2000, 64(2):261-269
[31]Jose Pla-Barber, Joaquin Alegre.Analysing the link between export intensity,innovation and firm size in a science-based industry[J].International Business Review, 2007, 16(3):275-293
[32]Colombo M G, Meoli M, Vismara S.Signaling in science-based IPOs: The combined effect of affiliation with prestigious universities,underwriters,and venture capitalists[J].Journal of Business Venturing, 2019, 34(1):141-177
[33]Munari F, Toschi L.Do venture capitalists have a bias against investment in academic spin-offs? Evidence from the micro-and nanotechnology sector in the UK[J].Industrial and Corporate Change, 2011, 20(2):397-432
[34]Gary Pisano.Profiting from innovation and the intellectual property revolution[J].Research Policy, 2006, 35(8):1122-1130
[35]Knockaert M,Ucbasaran D,Wright M,et al.The relationship between knowledge transfer, top management team composition,and performance: The case of science based entrepreneurial firms[J].Entrepreneurship Theory and Practice, 2011, 35(4):777-803
[36]Matti Karvonen, Tuomo K?ssi.Patent citations as a tool for analysing the early stages of convergence[J].Technological Forecasting & Social Change, 2013, 80(6):1094-1107
[37]方帅, 李欣融, 雷家骕.基于科学的企业内部治理问题:文献综述与研究展望[J].科技进步与对策, 2022, 39(16):1-8
[38]Gesing J, Antons D, Piening E P, et al.Joining forces or going it alone? On the interplay among external collaboration partner types,interfirm governance modes,and internal R & D[J].Journal of Product Innovation Management, 2015, 32(3):424-440
[39]Chen Y, Vanhaverbeke W, Du J.The interaction between internal R & D and different types of external knowledge sourcing: an empirical study of C hinese innovative firms[J].R& D Management, 2016, 46(S3):1006-1023
[40] 叶碧波.中国生物医药产业创业投资的风险研究[D].天津大学, 2010.
[41]Visintin F, Pittino D.Founding team composition and early performance of university—Based spin-off companies[J].Technovation, 2014, 34(1):31-43
[42]Sarfraz A.MianUniversity’s involvement in technology business incubation: what theory and practice tell us?[J].Int. J. of Entrepreneurship and Innovation Management, 2011, 13(2):113-121
[43]Rasmussen E, Wright M.How can universities facilitate academic spin-offs? An entrepreneurial competency perspective[J].The Journal of Technology Transfer, 2015, 40(5):782-799
[44]李欣融, 张庆芝, 雷家骕.基于科学的创新:研究回顾与展望[J].科研管理, 2022, 43(01):1-13
[45]陈虹, 杨雅程, 雷家骕.基于科学的企业演化的理论模型[J].科学学研究, 2019, 37(07):1268-1276
[46] 孟祥海, 高山行, 舒成利.生物技术药物发展现状及我国的对策研究[J].中国软科学, 2014(04):14-24.
[47]Rickne A.Connectivity and performance of science-based firms[J].Small business economics, 2006, 26(4):393-407
[48]杨淳, 肖广岭, 杜劭君.初始条件与新创科技企业生存[J].科研管理, 2020, 41(10):193-201
[49] Villani, E., Linder, C., & Grimaldi, R. (2018). Effectuation and causation in science-based new venture creation: A configurational approach. Journal of Business Research, 83, 173-185.
[50]Meoli M, Paleari S, Vismara S.Completing the technology transfer process: M&As of science-based IPOs[J].Small Business Economics, 2013, 40(2):227-248
[51]苏月, 刘楠.生物医药产业发展态势与对策[J].中国生物工程杂志, 2009, 29(11):123-128
[52]文思君, 唐守廉.行业规模、创新效率与企业生存关系的实证[J].统计与决策, 2020, 36(07):158-162
[53] 李淑云, 李平, 许家云.进口行为与企业生存——基于中国制造业企业微观数据的实证分析[J].南开经济研究, 2018(01):140-157.
[54]Garcia‐Castro R, Francoeur C.When more is not better: Complementarities,costs and contingencies in stakeholder management[J].Strategic Management Journal, 2016, 37(2):406-424
[55] 冯立杰, 李雪, 王金凤.创新网络架构特征组态对知识转移绩效的影响机制[J/OL].科技进步与对策:1-10[2022-11-24].
[56] 杜运周, 贾良定.组态视角与定性比较分析(QCA):管理学研究的一条新道路[J].管理世界, 2017(06):155-167.
[57]Colombo M G, Meoli M, Vismara S.Signaling in science-based IPOs: The combined effect of affiliation with prestigious universities,underwriters,and venture capitalists[J].Journal of Business Venturing, 2019, 34(1):141-177
[58] 康捷, 袁永, 胡海鹏.英国生物医药产业创新发展现状、经验及启示[J].特区经济, 2022(08):46-49. |